Benefits of recombinant activated factor VII in complicated liver transplantation

Transplantation Proceedings

Volumn 37, Issue 9, 2005, Pages 3919-3921

  Gala, B ^a   Quintela, J ^a   Aguirrezabalaga, J ^a   Fernandez C ^a   Fraguela, J ^a   Suarez F ^a   Gomez M ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADOLESCENT; ADULT; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; HEMOPHILIA A; HEMOSTASIS; HUMAN; LIVER TRANSPLANTATION; MORTALITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROPHYLAXIS; PROTHROMBIN TIME; RECIPIENT; TREATMENT OUTCOME;

FACTOR VIIA; HEMOPHILIA A; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER TRANSPLANTATION; PROTHROMBIN TIME; RECOMBINANT PROTEINS; THROMBOPOIETIN;

EID: 29544441018     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.10.070     Document Type: Conference Paper

References (7)

1. R.J. Porte, F.W.G. Leebeek Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery Drugs 62 2002 2193
2. A. Veldman, M. Hoffman, S. Ehrenforth New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa Current Medicinal Chemistry 10 2003 797
3. M.A. Wehbi, K. Obideen, E. Martínez Recombinant factor VIIa as a safe and effective therapeutic option for the correction of moderate to severe hepatic coagulopathy Hepatology 38 2003 482
4. T. Lisman, F.W.G. Leebeek, K. Meijer Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation Hepatology 35 2002 616
5. S.H. Caldwell, C. Chang, B.G. Macik Recombinant activated factor as haemostatic agent in liver disease a break from convention in need of controlled trials Hepatology 39 2004 592
6. M. Amin, D. Fergusson, K. Wilson The societal unit cost of allogenic red blood cells and red blood cell transfusion in Canada Transfusion 44 2004 1479
7. B. Custer Economic analyses of blood safety and transfusion medicine interventions a systematic review Transfus Med Rev 18 2004 127